期刊文献+

伴发迟发性运动障碍的精神分裂症患者血清脑源性神经营养因子水平的对照研究 被引量:2

Comparative study on serum levels of brain-derived neurotrophic factors between schizophrenic patients with tardive dyskinesia and those without tardive dyskinesia
下载PDF
导出
摘要 目的探讨外周血清脑源性神经营养因子(brain derived neurotrophic factor,BDNF)浓度与精神分裂症伴发的迟发性运动障碍(tadrive dyskinesia,TD)的关系。方法收集精神分裂症伴发TD患者61例、不伴发TD的患者78例,以及正常对照102名。用酶联免疫吸附法检测BDNF水平,采用不自主运动量表(abnormalinvoluntary movement scale,AIMS)评估TD的严重程度,阳性和阴性症状量表(positive and negative symptomscale,PANSS)评估患者精神症状。结果 TD组、非TD组和对照组的BDNF水平分别为(9.35±1.60)μg/L、(10.12±2.03)μg/L、(12.27±2.7)μg/L,3组的差异有统计学意义(F=37.8,P<0.01);两两比较显示,TD组和非TD组均低于对照组(P<0.01),而TD组又低于非TD组(P<0.05)。使用典型和非典型抗精神病药物患者之间的BDNF水平差异无统计学意义(P>0.05)。TD组BDNF水平与AIMS总分、年龄、总病程负相关(r分别为-0.24、-0.32、-0.22,P均小于0.05),而在非TD组BDNF水平与上述因素均无相关(P>0.05)。结论精神分裂症伴发TD患者外周BDNF浓度下降,且其水平与异常运动严重程度相关,提示BDNF可能在TD的病理生理中发挥作用。 Objective To explore relationship between serum levels of brain-derived neurotrophic factors (BD- NF) and tardive dyskinesia (TD) in schizophrenic patients with TD and those without TD. Methods All patients satisfied DSM-IV criteria for schizophrenia. The serum BDNF levels were examined by using enzyme linked immunosorbent assay in patients with TD (n = 61) and patients without TD (n = 78) and controls (n = 102). The severity of TD and psychopathology were assessed using the abnormal involuntary movement scale (AIMS) and positive and negative symp- tom scale (PANSS), respectively. Results The patients with TD [(9.35 ± 1.60)μg/LJ and those without TD [(10.12 ± 2.03)μg/L] had lower serum BDNF levels than normal controls [(12.27 ± 2.7)μg/Ll (F = 37.8,P 〈 0.01). The patients with TD had markedly lower serum BDNF levels than those without TD (P = 0.04). The serum BDNF levels of patients with TD was inversely correlated with AIMS total score, age and duration of illness. In all patients, no significantly differences in serum BDNF levels was noted between atypical and typical antipsychotic treatment [(9.78 ± 1.93)μg/L vs (10.10 ±2.20) μg/L, t = -0.88, P 〉 0.05]. Conclusion The BDNF levels of schizophrenia with TD was decreased significantly. There may be a relationship between decreased BDNF levels and dyskinetic movements. BDNF may play an important role in the pathophysiology of TD.
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2011年第10期614-617,共4页 Chinese Journal of Nervous and Mental Diseases
关键词 精神分裂症 脑源性神经营养因子 迟发性运动障碍 Schizophrenia Brain-derived neurotrophic factors Tardive dyskinesia
  • 相关文献

参考文献16

  • 1谢帆,王定省,宋立升,江开达.慢性精神分裂症住院病人迟发性运动障碍研究[J].中国神经精神疾病杂志,2002,28(1):27-29. 被引量:17
  • 2Modestin J,Wehrli MV,Stephan PL,et al.Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment[J].Schizophr Res,2008,100 (1-3):97-107.
  • 3Lohr JB,Kuczenski R,Niculescu AB.Oxidative mechanisms and tardive dyskinesia[J].CNS Drugs,2003,17(1):47-62.
  • 4Zhang WF,Tan YL,Zhang XY,et al.Extract of ginkgo biloba treatment for tardive dyskinesia in schizophrenia; a randomized,double-blind,placebo-controlled trial[J].J of Clinical Psychiatry,2011,72 (5):615-621.
  • 5Karege F,Schwald M,Cisse M.Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets[J].Neurosci Lett,2002,328(3):261-264.
  • 6Rizos EN,Rontos I,Laskos E,et al.Investigation of serum BDNF levels in drug-naive patients with schizophrenia[J] ,Prog Neuro-Psychopharmacol Biol Psychiatry,2008,32 (5):1308-1311.
  • 7Wang ZR,Zhou DF,Cao LY,et al.Brain-derived neurotrophic factor polymorphisms and smoking in schizophrenia[J].Schizophrenia Res,2007,97 (3):299-301.
  • 8谭云龙,周东丰,邹义壮,曹连元,苏建民,姚付新.精神分裂症迟发性运动障碍患者血清脑源性神经营养因子水平研究[J].中国神经精神疾病杂志,2004,30(5):332-334. 被引量:7
  • 9Schooler N R,Kane JM.Research diagnoses for tardive dyskinesia[J].Arch Gen Psychiatry,1982,39(4):486-487.
  • 10Fachinetto R,Villarinho JC,Wagner C,et al.Valeriana officinalis does not alter the orofacial dyskinesia induced by haloperidol in rats; role of dopamine transporter[J].Prog Neuro-psychopharmacol Biol Psychiatry,2007,31(7):1478-1486.

二级参考文献25

  • 1朱风艳,费立鹏,Jefrey A. Lieberman.长期住院病人的迟发性运动障碍调查[J].上海精神医学,1996,8(3):128-132. 被引量:6
  • 2颜文伟 康伟民 等.迟发性运动障碍的流行病学调查[J].上海精神医学,1986,4(4):192-192.
  • 3Hyman CM, Hofer YA, Brade M, et al. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature, 1991, 350(3):230.
  • 4Ahmed ME, Richard JW. Tardive dyskinesia: Possible Involvement of Free Radicals and treatment with vitamin E. Schizophrenia Bulletin,1999, 25(4) :731.
  • 5Schooler NR, Kane JM. Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry, 1982, 39(2) :486.
  • 6Durany NT, Michel RZ, Boissl KW, et al. Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses. Schizophr Res,2001, 52(1-2):79.
  • 7Eiji Shimizu, Kenji Hashimoto, Hiroyuki Watanabe, et al. Serum brainderived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls. Neuroscience Letters, 2003, 351(2): 111.
  • 8Guillin O J, Diaz P, Carroll N, Griffon, et al. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature,2001, 411(1):86.
  • 9Lewin GR,Barde YA.Physiology of the neuortorphins[J].Annu Rev Neurosc,1996,19(2):289-317.
  • 10Rizos EN,Rontos I,Laskos E,et al.Investigation of serum BDNF levels in drug-naive patients with schizophrenia[J].Prog Neuro-Psychopharmacol Biol Psychiatry,2008,32(5):1308-1311.

共引文献57

同被引文献32

  • 1王坚.中枢神经系统运动障碍的诊断和处理[J].神经病学与神经康复学杂志,2010,7(3):187-189. 被引量:5
  • 2Bishnoi M, Kumar A, Chopra K.Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskincsia[J].Indian Journal of Experimental Biology, 2007, 29 ( 2 ) : 4521-4523.
  • 3Ivanova S A, A1Hadithy A F Y.No involvement of the adenosine A2A receptor in tardive dyskinesia in Russian psychiatric inpatients from Siberla[J].Hurnanpsychopharmaeology, 2012, 32 (3): 543-546.
  • 4Bachus S E, Yang E.Parallels between behavioral and neurochemical variability in the rat vacuous chewing riaovement model of tardive dyskinesia[J].Behavioural Brain Research, 2012, 38 ( 32 ) : 569-670.
  • 5Basile V S, Ozdemir.A functional polymorphisra of the cytochrome P450 1A2 ( CYP1A2 ) gene: association with tardive dyskinesia in schizophrenia[J].Molecular Psychiatry, 2010, 25 ( 8 ) : 3685-3686.
  • 6Soares K V, McGrath J J.Use of Peripheral Nerve Field Stimulation for Treatment of Pain Originating from Tardive Dyskinesia[J].Journal ofmusculoskeletal pain, 2012, 38 (2) : 987-989.
  • 7Flashinan LA,Green MF.Review of cognition and brain structure in schizophrenia:Profiles,longitudinal course, and effect oftreatment[J]. Psychiatric Clinical North Am, 2013,24(9) : 126-129.
  • 8Patterson SL,Abel T, Deuel TA,et al. Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice[J]. Neuron, 1996, 16(6) : 1137-1145.
  • 9Medalia A,Lim R. Treatment of cognitive dysfunction in psychiatirc disorders[J]. Journal of Psychiatric Practice, 2004,10(1 ) : 17-25.
  • 10Szekeres G,Juhasz A,Rimano'czy A. The C270T polymor- phism of the brain-derived neuretrophic factor gene is associated with chizophrenia[J]. Schizophrenia Research, 2003,65(1) : 15-18.

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部